Allurion Technologies (NYSE:ALUR – Get Free Report) and Apyx Medical (NASDAQ:APYX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.
Profitability
This table compares Allurion Technologies and Apyx Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Allurion Technologies | -199.96% | N/A | -77.13% |
| Apyx Medical | -21.22% | -114.95% | -18.49% |
Institutional & Insider Ownership
21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 8.1% of Allurion Technologies shares are held by company insiders. Comparatively, 15.2% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Risk & Volatility
Analyst Recommendations
This is a summary of recent ratings and price targets for Allurion Technologies and Apyx Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Allurion Technologies | 1 | 1 | 1 | 0 | 2.00 |
| Apyx Medical | 1 | 1 | 3 | 1 | 2.67 |
Allurion Technologies presently has a consensus target price of $3.00, indicating a potential upside of 341.18%. Apyx Medical has a consensus target price of $6.50, indicating a potential upside of 122.60%. Given Allurion Technologies’ higher possible upside, research analysts clearly believe Allurion Technologies is more favorable than Apyx Medical.
Valuation and Earnings
This table compares Allurion Technologies and Apyx Medical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Allurion Technologies | $17.21 million | 0.59 | -$7.20 million | ($10.56) | -0.06 |
| Apyx Medical | $52.84 million | 2.31 | -$11.21 million | ($0.27) | -10.81 |
Allurion Technologies has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Apyx Medical beats Allurion Technologies on 11 of the 15 factors compared between the two stocks.
About Allurion Technologies
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
